Kenvue is parent to a host of household name brands, including Tylenol, Listerine, Band-Aid, Neutrogena and Nicorette
Read More...
![](https://outperformdaily.com/wp-content/uploads/2023/05/ipo-report-jjs-kenvue-spinoff-to-hit-ipo-market-this-week-in-the-biggest-deal-since-late-2021.jpg)
Johnson & Johnson’s consumer health company Kenvue is expected to hit the initial public offering market this week and mark the largest deal since late 2021.
Kenvue is parent to a host of household name brands, including Tylenol, Listerine, Band-Aid, Neutrogena and Nicorette.
“With over $2 billion in cash flow and a healthy 3.7% dividend,…
Add Comment